Skip to main content
Premium Trial:

Request an Annual Quote

Byron Hewett, Edward Erickson, Jean-Francois Formela, Kurt Petersen, CombiMatrix

Premium

Pairings

Immunicon's board of directors has elected Byron Hewett as president and chief operating officer, the company announced today.

Previously, Hewett was the company's COO and general manager of cancer products. Hewett joined Immunicon in October 2004 after spending 20 years in healthcare and life sciences management. He was senior vice president of sales and marketing and general manager for North America for Qiagen and vice-president of worldwide marketing for Bayer Diagnostics (previously Chiron Diagnostics).

He received his Master's degree in management from Northwestern University's J.L. Kellogg Graduate School of Management and a B.Sc. from the University of Virginia's McIntire School of Commerce.

The company also announced that its chief executive officer, Edward Erickson, will step down from his post on March 31, 2006. Erickson will remain chairman.


DeCode genetics announced Jean-Francois Formela has resigned from its board of directors, effective today.

Formela, a senior partner at Atlas Venture, has served on deCODE's board since the formation of the company in 1996. He resigned to devote his time to a new Atlas fund.

Atlas was a member of the group of venture firms that helped finance deCODE's start.


Kurt Petersen resigned from Cepheid's board of directors on Dec. 19, according to documents filed with the Securities Exchange Commission late last week. Petersen's resignation will be effective as of Dec. 31.

Currently the chief executive officer and a director of SiTime, Petersen co-founded Cepheid and served as president from August 1996 to August 2004. He was also the company's chief operating officer from 1996 to 2003 and the chief technical officer from 2003 to 2004. He has been a Cepheid director since August 1996.

New Releases

CombiMatrix this week launched a series of microarrays designed for microRNA analysis, the company said in a statement. The arrays "can be used in studies for human, dog, rat, mouse, and other plants and animals," CombiMatrix said. The company intends to update each of the arrays as new miRNA sequences are discovered, it added.

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.